The Irish Times

Teva betting on Schultz as CEO with $40m package

Dane lands top job with beleaguered generics giant after reviving Lundbeck’s fortunes

Mon Sept 11 2017 - 22:05

Israel company expects earnings per share of $4.90-$5.30 on revenue of $23.8bn-$24.5bn

Fri Jan 06 2017 - 17:17

Pharmaceutical acquisition was announced a year ago with $40.5bn price tag

Wed Aug 03 2016 - 08:24

Bolt-on acqusition strengthens position in Europe amid three-way takeover battle

Tue Jun 02 2015 - 19:34

Mylan adopts poison-pill defence and renews commitment to Perrigo deal

Wed Apr 22 2015 - 01:00

Firm bolsters its business of making drugs to treat disease of the central nervous system

Mon Mar 30 2015 - 12:30

Demand will create ‘inexorable upward pressure’ despite efforts by minister to cut the costs

Fri May 02 2014 - 08:35